IACE2/I and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury

COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that...

Full description

Saved in:
Bibliographic Details
Published inMedicina (Kaunas, Lithuania) Vol. 59; no. 9
Main Authors Lin, Cheng-Han, Chen, Yi-Ju, Lin, Meng-Wei, Chang, Ho-Ju, Yang, Xin-Rui, Lin, Chih-Sheng
Format Journal Article
LanguageEnglish
Published MDPI AG 01.08.2023
Subjects
Analysis
Ethylenediaminetetraacetic acid
Genetically modified organisms
Health aspects
Hydrochloric acid
Inflammation
Lung diseases
Medical research
Medicine, Chinese
Medicine, Experimental
China
Taiwan
Online AccessGet full text

Cover

More Information
Summary:COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS-CoV-2 pathogenicity is the limited availability of animal models. Therefore, it is necessary to establish animal models that can reproduce multiple characteristics of ALI to study therapeutic applications. The present study established a mouse model that has features of ALI that are similar to COVID-19 syndrome to investigate the role of ACE2 and the administration of the Chinese herbal prescription NRICM101 in ALI. Mice with genetic modifications, including overexpression of human ACE2 (K18-hACE2 TG) and absence of ACE2 (mACE2 KO), were intratracheally instillated with hydrochloric acid. The acid intratracheal instillation induced severe immune cell infiltration, cytokine storms, and pulmonary disease in mice. Compared with K18-hACE2 TG mice, mACE2 KO mice exhibited dramatically increased levels of multiple inflammatory cytokines (IL-6 and TNF-α) in bronchoalveolar lavage fluid, histological evidence of lung injury, and dysregulation of MAPK and MMP activation. In mACE2 KO mice, NRICM101 could ameliorate the disease progression of acid-induced ALI. In conclusion, the established mouse model provided an effective platform for researchers to investigate pathological mechanisms and develop therapeutic strategies for ALI, including COVID-19-related ALI.
ISSN:1648-9144
1648-9144
DOI:10.3390/medicina59091554